Forensic laboratories are an important resource in assisting local, state and federal law enforcement agencies in monitoring and combating illicit drug abuse and trafficking, including the diversion of legally-manufactured pharmaceuticals into illegal markets. For example, data collected by the DEA from forensic laboratories about the regional use of prescription pain medicines like oxycodone and hydrocodone for non-medical purposes informs drug policy and drug enforcement initiatives and helps solve crimes. Each year, several million seized drug items are analyzed by the nation's network of government and private forensic laboratories.
Since 2004, the DEA has applied Waters ACQUITY UltraPerformance LC(R) (UPLC(R)) technology for drug profiling and has investigated this technology for drug screening analyses.
For drug profiling applications, where experts analyze trace impurities such as precursor chemicals in synthetic drugs or the constituents of natural products such as those derived from opium, a combination of UPLC and mass spectrometry (UPLC/MS/MS) has been shown to offer 2X better resolving power than HPLC and greater specificity and sensitivity than HPLC paired with photodiode array detection. These trace impurities can be important in matching a seized drug to a particular individual and potentially linking it to other cases where a similar impurity profile has been generated.
The DEA's most recent acquisition of an ACQUITY UPLC System complements its growing number of Waters ACQUITY UPLC and UPLC/MS/MS analytical systems deployed at DEA laboratories around the country.
For more information on Waters products for UPLC, visit www.waters.com/uplc.
For 50 years,
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
With revenue of
Waters, ACQUITY, UPLC, UltraPerformance LC, and ACQUITY UPLC are
Waters Corporation-0- 04/29/2009/CONTACT: Brian J. Murphy, Public Relations Manager of Waters Corporation, +1-508-482-2614, email@example.com/ /Web Site: http://www.waters.com / (WAT) CO: Waters Corporation; United States Drug Enforcement Administration; U.S. DEA ST: Massachusetts, VirginiaIN: CHM MTC PHA SU: EXE CON LAW PR -- NE06780 -- 1880 04/29/2009 10:00 EDThttp://www.prnewswire.com